On the other hand, alternative mechanisms of biallelic MBD4 inactivation have been described: in CRC frameshift mutations were accompanied by loss of heterozygosity (LOH) of the wild type allele [17]; and silencing of MBD4 by promoter hypermethylation can occur in CRC and ovarian cancer [23]. Here, MBD4 is linked to ovarian cancer.